Suvoda Awarded US Patent for its eCOA Software Architecture
Low-code, no-code approach accelerates eCOA questionnaire design and deployment, taking questionnaire creation, licensing, and localization off the critical path PHILADELPHIA, Nov. 14, 2024 /PRNewswire/
Suvoda, a global clinical trial technology company specializing in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare diseases, announced the receipt of a Patent from the US Patent Office for the Suvoda Questionnaire Definition Language (SQDL), part of the Software Architecture of its eCOA (electronic Clinical Outcome Assessment) product. The Patent demonstrates the power of Suvoda eCOA: expedited questionnaire creation, translation, localization, and deployment so clinical trial sponsors can launch their studies more efficiently. While eCOA is traditionally a bottleneck in clinical trial implementation, Suvoda eCOA and its SQDL tool enable sponsors to deliver high quality questionnaires in a matter of hours, instead of days.![Suvoda Awarded US Patent for its eCOA Software Architecture]( "Suvoda Awarded da Liberoquotidiano.it")
Leggi su Liberoquotidiano.it
Suvoda, a global clinical trial technology company specializing in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare diseases, announced the receipt of a Patent from the US Patent Office for the Suvoda Questionnaire Definition Language (SQDL), part of the Software Architecture of its eCOA (electronic Clinical Outcome Assessment) product. The Patent demonstrates the power of Suvoda eCOA: expedited questionnaire creation, translation, localization, and deployment so clinical trial sponsors can launch their studies more efficiently. While eCOA is traditionally a bottleneck in clinical trial implementation, Suvoda eCOA and its SQDL tool enable sponsors to deliver high quality questionnaires in a matter of hours, instead of days.
Liberoquotidiano.it - Suvoda Awarded US Patent for its eCOA Software Architecture
- Suvoda Awarded US Patent for its eCOA Software Architecture - Low-code, no-code approach accelerates eCOA questionnaire design and deployment, taking questionnaire creation, licensing, and localization off the critical path ... (adnkronos.com)
- FDA approves Herceptin biosimilar as US patent expires - The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry. Herceptin’s main US patent expires this month ... (pharmaphorum.com)
- HUMBL issued US patent for blockchain payments technology - The patent was issued on Oct. 15 for HUMBL’s nebulously titled “System and Method for Transferring Currency Using Blockchain.” While this isn’t the first company to receive a US patent for ... (cointelegraph.com)
Infortunio Kalulu, ecco il primo aggiornamento di Thiago Motta: cosa ha detto sulle condizioni del difensore juventusnews24.com
Barella: «Vittoria di squadra. Milan? Lottiamo per vincere il titolo» inter-news.it
Civitavecchia, sfida tra eolico e plastica ilmanifesto.it
Reale Mutua Torino, pesante sconfitta all'Unieuro Arena: Forlì vince con +19 di scarto torinotoday.it
Basket, serie A2 | Libertas Livorno-Gruppo Mascio Orzinuovi: sinfonia di triple, dominio Libertas al ... livornotoday.it
Tuttosport – Juve, le possibili avversarie ai playoff di Champions e agli ottavi justcalcio.com
De Pieri: «Esordio all’Inter? Emozioni indescribili. Inzaghi mi ha detto questo!» inter-news.it
Barella: «Vittoria di squadra. Milan? Lottiamo per vincere il titolo» inter-news.it
Civitavecchia, sfida tra eolico e plastica ilmanifesto.it
Reale Mutua Torino, pesante sconfitta all'Unieuro Arena: Forlì vince con +19 di scarto torinotoday.it
Basket, serie A2 | Libertas Livorno-Gruppo Mascio Orzinuovi: sinfonia di triple, dominio Libertas al ... livornotoday.it
Tuttosport – Juve, le possibili avversarie ai playoff di Champions e agli ottavi justcalcio.com
De Pieri: «Esordio all’Inter? Emozioni indescribili. Inzaghi mi ha detto questo!» inter-news.it
Video Suvoda Awarded
